Home › Non-Muscle Invasive Bladder Cancer › Illinois
Non-Muscle Invasive Bladder Cancer clinical trials in Illinois
11 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in Illinois.
Cities in Illinois
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Northwestern University, Chicago
- University of Illinois, Chicago
- Loyola University Medical Center, Maywood
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07000084A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Associated Urological Specialists - Chicago Ridge ( Site 0139), Chicago Ridge
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06833073Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Associated Urological Specialists, Chicago Ridge
- Duly Health and Care, Lisle
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06995677A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Associated Urological Specialists, Chicago Ridge
- UroPartners, Glenview
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06919965A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- Northwestern Memorial Hospital, Chicago
- Northwestern University - Feinberg School of Medicine, Chicago
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07206225A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
- Associated Urological Specialists, Chicago Ridge
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07309445A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
- Northwestern University ( Site 0051), Chicago
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT06637423Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Comprehensive Urologic Care, Lake Barrington
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT05951179FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- The University of Chicago Medical Center (UCMC), Chicago
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05614739Blue Light Cystoscopy With Cysview® Registry
- Northwestern University, Chicago
- Northshore University Health System, Evanston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT02660645Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
- Site 02-012 - University of Chicago, Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 24, 2025 · NCT03945162From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.